Learning how to get funding from Optum Ventures means pitching the venture arm of Optum, itself part of UnitedHealth Group: ‘investing in extraordinary entrepreneurs to transform healthcare together.’ The thesis backs data-driven technologies that improve consumers’ access to care, change how care is delivered and paid for, and make the system more reliable and easier to navigate — across digital health, healthcare data and analytics, AI in healthcare, behavioral health and life-sciences platforms.

Investment thesis

The fund launched in November 2017 with $250 million, expanded in 2018 with a $100M Global Fund, and reached up to $600M in total commitments (per Medical Design & Outsourcing, 2018). It invests at startup and early stage and has led Series A rounds — including Holmusk’s $21.5M Series A (May 2020) and Oxford VR’s $12.5M Series A. Portfolio companies get strategic guidance through Optum’s expert network and a ‘proving ground’ of Optum analytics capabilities (per the 2017 launch release) — the classic corporate-VC edge: distribution and data, not just dollars.

Sectors, stages and cheque size

Optum Ventures focuses on digital health, healthcare data and analytics, AI in healthcare, behavioral health, life-sciences platforms. Stage: startup and early-stage; US-focused, with offices in Boston and London. Fund: $250M initial (2017), up to $600M total commitments; early-stage, leads Series A/B.

Notable portfolio

  • Holmusk — led $21.5M Series A, May 2020 — PR Newswire UK; Singapore HQ
  • Oxford VR — led $12.5M Series A — hitconsultant.net
  • Apervita — 2017 launch release
  • Buoy Health — 2017 launch release
  • Kaia Health — hitconsultant.net

Key people

  • Larry Renfro, Managing Partner from 2018; former Optum CEO, per Medical Design & Outsourcing
  • A.G. Breitenstein, Partner at launch; co-founded Humedica (acquired by Optum 2013), per Modern Healthcare
  • Virginia McFerran, Partner at launch; former president/CEO of Optum Analytics, per Modern Healthcare

India connection

No verified India investments or office (the Holmusk bet is Singapore-headquartered). But Indian healthtech founders selling into the US should pay attention — Optum is the distribution.

How to apply for funding

Email [email protected] — the address is listed on the official site. Come with a data-driven product and a clear view of how Optum’s network (payers, providers, analytics) accelerates your go-to-market.

Why it matters for founders

Optum Ventures is corporate venture done right: real fund scale, real lead-investor behavior, and a parent whose data and distribution can make a healthtech startup. The $600M commitment figure tells you it is not a dabble. If your product touches US healthcare workflows, [email protected] is a credible front door — lead with outcomes data.